Serial changes in high‐sensitive troponin I predict outcome in patients with decompensated heart failure

The aim of this study was to evaluate the prognostic utility of small troponin I (TnI) elevations, serial TnI measurements, and the combination of TnI and brain natriuretic peptide (BNP) in patients with decompensated heart failure (HF).

[1]  M. Emdin,et al.  Old and new biomarkers of heart failure , 2009, European journal of heart failure.

[2]  R. Fitzgerald,et al.  Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure. , 2008, Journal of cardiac failure.

[3]  E. Barrett-Connor,et al.  Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. , 2008, Journal of the American College of Cardiology.

[4]  M. Nieminen,et al.  Clinical significance of cardiac troponins I and T in acute heart failure , 2008, European journal of heart failure.

[5]  G. Fonarow,et al.  Cardiac troponin and outcome in acute heart failure. , 2008, The New England journal of medicine.

[6]  R. Fitzgerald,et al.  Pro-B-type natriuretic peptide levels in acute decompensated heart failure. , 2008, Journal of the American College of Cardiology.

[7]  C. Phillips,et al.  Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. , 2008, The American journal of cardiology.

[8]  Takeshi Kimura,et al.  Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies , 2006, Heart and Vessels.

[9]  Elizabeth Sykes,et al.  Analytical relationships among Biosite, Bayer, and Roche methods for BNP and NT-proBNP. , 2005, American journal of clinical pathology.

[10]  K. Swedberg,et al.  Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure. , 2005, The Canadian journal of cardiology.

[11]  A. Seeberger,et al.  Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction , 2004, Scandinavian journal of clinical and laboratory investigation.

[12]  H. Naruse,et al.  Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. , 2003, Clinical chemistry.

[13]  Y. Dohi,et al.  Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure , 2003, Heart.

[14]  G. Fonarow,et al.  Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure , 2003, Circulation.

[15]  G. Fonarow,et al.  Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. , 2003, Reviews in cardiovascular medicine.

[16]  H. Naruse,et al.  Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. , 2002, The American journal of cardiology.

[17]  K. Thygesen,et al.  Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) , 2001 .

[18]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[19]  M. Garami,et al.  Mechanical Strain Increases Expression of the Brain Natriuretic Peptide Gene in Rat Cardiac Myocytes* , 1997, Journal of Biological Chemistry.

[20]  K. Haider,et al.  Cardiac troponin-I: a biochemical marker for cardiac cell necrosis. , 1993, Disease markers.